Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Charles Weston
RBC
Charles Weston
Wall Street Analyst
Not yet ranked — too few measurable calls.
50%
Success Rate
+0.9%
Average Return
1 of 2 calls profitable · +44.2% vs benchmark
📈 Across the calls we could measure, roughly 50% of Charles Weston's ratings turned a profit when each position was held for 1 year — averaging +0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

60 Buy 25 Hold 0 Sell
Charles's Stock Coverage 22 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
IT:1SXP
SCHOTT Pharma AG & Co. KGaA
Jun 17, 2026 HOLD Buy
+22.2% avg upside
5 analysts
$18.00
8.10% Upside
·
GB:4BB
4basebio UK Societas
Jun 15, 2026 BUY Strong Buy
+166.6% avg upside
1 analyst
$1400.00
166.61% Upside
·
CH:BANB
Bachem Holding AG
Jun 09, 2026 BUY Hold
+28.0% avg upside
3 analysts
$110.00
61.80% Upside
·
GB:OXB
Oxford BioMedica
Jun 03, 2026 BUY Buy
+95.0% avg upside
3 analysts
$1170.00
95.03% Upside
·
GB:ONT
Oxford Nanopore Technologies PLC
May 26, 2026 BUY Strong Buy
+77.9% avg upside
6 analysts
$225.00
93.16% Upside
·
DE:AFX
Carl Zeiss Meditec
May 12, 2026 HOLD Hold
+91.0% avg upside
13 analysts
$32.00
28.33% Upside
·
CH:LONN
Lonza Group Ltd
May 08, 2026 BUY Strong Buy
+26.0% avg upside
19 analysts
$670.00
34.43% Upside
·
DE:SRT3
Sartorius
May 06, 2026 HOLD Buy
+27.9% avg upside
17 analysts
$220.00
3.22% Upside
·
FR:DIM
Sartorius Stedim Biotech
May 06, 2026 BUY Strong Buy
+54.5% avg upside
10 analysts
$210.00
28.62% Upside
·
DE:EVT
Evotec
May 04, 2026 BUY Buy
+258.9% avg upside
8 analysts
$10.00
115.90% Upside
·
CH:PPGN
PolyPeptide Group AG
Apr 13, 2026 BUY Strong Buy
-17.5% avg upside
3 analysts
$44.00
11.75% Upside
·
CH:SFZN
Siegfried Holding AG
Mar 16, 2026 HOLD Strong Buy
+41.2% avg upside
2 analysts
$96.00
41.20% Upside
·
GB:CVSG
CVS Group plc
Mar 04, 2026 BUY Strong Buy
+41.9% avg upside
2 analysts
$1900.00
61.05% Upside
·
GB:UPR
Uniphar PLC
Feb 24, 2026 BUY Strong Buy
+0.9% avg upside
3 analysts
$415.14
3.35% Upside
·
LZAGY
Lonza Group
Feb 11, 2026 BUY Strong Buy
+39.6% avg upside
2 analysts
-1.3%
SSB
SouthState Corporation
Jan 07, 2025 BUY Strong Buy
+37.0% avg upside
15 analysts
$290.33
200.86% Upside
+3.0%
GB:SPI
Spire Healthcare
Nov 19, 2024 BUY Strong Buy
+35.7% avg upside
5 analysts
$310.00
43.47% Upside
·
GB:CTEC
ConvaTec
Mar 23, 2023 HOLD Strong Buy
+41.3% avg upside
16 analysts
$215.00
3.85% Upside
·
CH:MOLN
Molecular Partners AG
Jul 12, 2021 BUY Strong Buy
+560.3% avg upside
5 analysts
$26.00
741.34% Upside
·
SE:HNSA
Hansa Biopharma AB
Apr 13, 2021 BUY Strong Buy
+335.3% avg upside
4 analysts
$287.00
790.74% Upside
·
GB:IPO
IP Group plc
Nov 02, 2018 BUY Strong Buy
+7352.8% avg upside
3 analysts
$160.00
147.32% Upside
·
MDXH
MDxHealth
Apr 24, 2018 BUY Strong Buy
+1073.0% avg upside
8 analysts
$7.08
1204.57% Upside
·
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Charles Weston — Frequently Asked Questions
How accurate are Charles Weston's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Charles's ratings were profitable over a one-year hold, with an average return of +0.9% per rating, or -12.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Charles ranked on 13Foresight?
Charles Weston is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Charles cover?
Charles most recently has ratings on IT:1SXP, GB:4BB, CH:BANB, GB:OXB, GB:ONT, DE:AFX, CH:LONN, DE:SRT3, FR:DIM, DE:EVT, CH:PPGN, CH:SFZN and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.